Liu et al.138 found that both genetic and pharmacological inhibition of PERK shortened Q and T waves on ECGs (thus shortening QTc intervals), decreased ventricular tachycardia episodes, and heightened survival rates after MI, suggesting that inhibiting PERK may reduce arrhythmia risk after MI. The gene discussed is EIF2AK3; the disease is myocardial infarction.